Literature DB >> 17567871

Quality of life after restorative proctocolectomy for ulcerative colitis: preoperative status and long-term results.

Mirjam Tariverdian1, Christine Leowardi, Ulf Hinz, Thilo Welsch, Jan Schmidt, Peter Kienle.   

Abstract

BACKGROUND: Restorative proctocolectomy has become the surgical procedure of choice in patients with ulcerative colitis. Only smaller studies have compared postoperative to preoperative quality of life (QoL).
METHODS: Patients with ulcerative colitis who had undergone restorative proctocolectomy at least 5 years before and who had filled out a disease-specific validated questionnaire (Gastrointestinal Quality of Life Index, GIQLI) prior to surgery (n = 128) were included into this follow-up study. Factors potentially influencing QoL at the time of operation were investigated with regard to pre- and postoperative QoL in univariate and multivariate analysis.
RESULTS: A total of 105 patients responded (82%). QoL at least 5 years after colectomy was significantly improved compared to the preoperative situation (109 versus 75). This improvement was evident in all 5 dimensions (P < 0.0001). The Colitis Activity Index (CAI) (P < 0.00001), a shorter duration of the disease (P < 0.05), and a 3-staged procedure (<0.001) were negatively correlated with preoperative QoL, whereas neoplasia (P < 0.001) was positively correlated. Colectomy was the reason for most of the increase in QoL. Ileostomy closure resulted in a further improvement in 3 of 5 dimensions but not in overall QoL. Uni- and multivariate analysis of the difference in QoL before and 5 years after colectomy revealed CAI, the type of operation (both P < 0.001), and neoplasia as significant factors (P < 0.05).
CONCLUSIONS: The patients in the worst clinical situation profit the most from restorative proctocolectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17567871     DOI: 10.1002/ibd.20175

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

1.  Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis.

Authors:  Christine Leowardi; Ulf Hinz; Mirjam Tariverdian; Peter Kienle; Christian Herfarth; Alexis Ulrich; Martina Kadmon
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

Review 2.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

Review 3.  [Restorative proctocolectomy for ulcerative colitis : Long-term functional results and quality of life].

Authors:  E Rijcken; N Senninger; R Mennigen
Journal:  Chirurg       Date:  2017-07       Impact factor: 0.955

4.  Is pyloric gland metaplasia in ileal pouch biopsies a marker for Crohn's disease?

Authors:  Shuchi Agarwal; Arthur F Stucchi; Kleanthis Dendrinos; Sandra Cerda; Michael J O'Brien; James M Becker; Timothy Heeren; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2013-03-30       Impact factor: 3.199

5.  Long-term quality of life after ileal pouch anal restorative proctocolectomy for ulcerative colitis.

Authors:  Babak Salehimarzijarani; Niloofar Yahyapour Jalaly; Zohreh Dadvar; Gholamreza Hemmasi; Maryam Ashrafi; Mohammadreza Zali
Journal:  Indian J Gastroenterol       Date:  2012-12-13

Review 6.  Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?

Authors:  Gianluca Rizzo; Daniela Pugliese; Alessandro Armuzzi; Claudio Coco
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

7.  Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.

Authors:  Ellen de Bock; Mando D Filipe; Vincent Meij; Bas Oldenburg; Fiona D M van Schaik; Okan W Bastian; Herma F Fidder; Menno R Vriens; Milan C Richir
Journal:  BMJ Open Gastroenterol       Date:  2021-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.